skip to main
|
skip to sidebar
Pages
Home
Clinical Research
Post Your CV
Post News
Policies
Contact Us
Facebook
Twitter
RSS
Email
Clinical Trial News
Drop Menu 1 »
Child Menu 1.1
Child Menu 1.2
Child Menu 1.3
Drop Menu 2 »
Child Menu 2.1
Child Menu 2.2
Child Menu 2.3
Drop Menu 3 »
Child Menu 3.1
Child Menu 3.2
Child Menu 3.3
Drop Menu 4 »
Child Menu 4.1
Child Menu 4.2
Child Menu 4.3
Clinical Trial News
Saturday, March 5, 2011
P29HMW8R7FGU
Posted by
Ajay Shahi
at
3/05/2011 12:48:00 AM
0 comments
Email This
BlogThis!
Share to X
Share to Facebook
Share to Pinterest
P29HMW8R7FGU
Leave a Reply
Newer Post
Older Post
Subscribe to:
Post Comments (Atom)
Recent
Popular
Label
Popular Posts
Ban on anti-anxiety drug Deanxit in pipeline
The Government may soon ban the controversial anti-anxiety drug Deanxit, a combination of two psycho-active agents being frequently pr...
Enzo Biochem Initiates Clinical Trial for Treatment of Uveitis at NIH
Enzo Biochem, Inc. announced that, following filing of a investigational new drug (IND) application with the FDA, its Enzo ...
Targeted Therapy Shows Promise Against Deadly Brain Cancer
A preliminary study has found that a targeted treatment for medulloblastoma -- the most common malignant brain cancer in children -- may o...
CorMedix Doses First Patient in Phase II Clinical Trial of CRMD-001
CorMedix Inc. ("CorMedix") , a pharmaceutical company focused on developing and commercializing therapeutic products for the p...
BMS, Pfizer halt phase-3 AVERROES trial of apixaban in atrial fibrillation
Bristol-Myers Squibb Company (BMS) and Pfizer announced that the companies have agreed to stop the phase 3 AVERROES clinical trial of apix...
Unauthorized Clinical Trials on Bhopal Victims
Ajay Shrivastav from Bhopal, the central Indian city that witnessed one of the worst industrial disasters of the world in 1984 from a dead...
FDA to Host Public Meeting on Oversight of Laboratory-Developed Tests
The U.S. Food and Drug Administration today announced plans to hold a public meeting on July 19-20, 2010, to discuss how the agency will ov...
Promising Results For New Recurrent Ovarian Cancer Treatment - AMG 386 Combined With Paclitaxel
AMG 386 combined with paclitaxel gave promising antitumor results in a randomized Phase 2 trial involving 161 patients with recurrent ovaria...
Stempeutics Research gets DCGI clearance for Stempeucel
Stempeutics Research, a group company of Manipal Education & Medical Group announced today that Drug Controller General of India (DC...
Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rH...
Blog Archive
Blog Archive
April 2012 (2)
March 2012 (4)
February 2012 (10)
January 2012 (20)
December 2011 (10)
November 2011 (5)
October 2011 (9)
September 2011 (7)
August 2011 (1)
July 2011 (7)
June 2011 (3)
May 2011 (21)
April 2011 (12)
March 2011 (45)
February 2011 (15)
January 2011 (4)
December 2010 (8)
November 2010 (9)
October 2010 (2)
September 2010 (1)
August 2010 (2)
July 2010 (20)
June 2010 (34)
May 2010 (33)
Clinical Research News
© 2012
crtnews.co.cc
. Supported by
Sai Clinical Services